Norn founder at Foresight: AI-driven longevity drug breakthroughs need physiological data, not just 'more data'
juanbenet · x · 2026-11-15
Norn Group founder Martin Bjeld Jensen spoke at Foresight Institute's Vision Weekend USA in San Francisco on 'Making AI Work for Longevity,' arguing that the bottleneck for AI in biology isn't data quantity but data type: breakthrough cures require physiological data from organs and organisms, experiments that take months or years — so the data generation must start now.
An accompanying slide draws an analogy: just as the industry pre-builds datacenters for anticipated compute demand, we should pre-build scientific data. The slide shows reasoning capability rising steeply toward 2026 while relevant data growth lags far below the threshold needed for breakthroughs through 2030.
More from AGI Musings
- Dev laments generative AI debate has collapsed into nuance-free black-and-white thinking — burny_tech · 2026-11-15
- Pro-AI takes now trigger harassment waves from anti-AI zealots, dev community pushes back — burny_tech · 2026-11-15
- What Happens When AI Beats Most People at Most Work? — IagoInTheLight · 2026-11-15
- Fed survey: AI-adopting firms' revenue growth outlook net gap hits 48.2 pts, 2x+ non-adopters — AccBalanced · 2026-11-15
- No benchmark is hard anymore: Fable 5.2 tops SimpleQA, arbitrary jumps ahead — teortaxesTex · 2026-11-15
- AI Circles Lament Nick Land Posting Through Takeoff While Bostrom and Omohundro Stay Silent — abhiadesai · 2026-11-15